The triple tandem repeat (3R variant) and the insertion (ins) allele have been associated with increased TYMS expression and decreased survival in CRC patients treated with 5-FU based chemotherapy [5,21,22,23,24]. The gene discussed is TYMS; the disease is colorectal carcinoma.